Gagandeep Kang

Known for interdisciplinary research on the transmission, development and prevention of enteric infections and their sequelae in children in India, Dr. Kang’s current studies include active hospital and community-based surveillance and clinical trials of new and existing vaccines, including the use of molecular assays to study pathogen diversity and immune responses in children with viral and parasitic enteric infections. She has also established training programs for students and young faculty in clinical translational medicine, with the goal of building a cadre of clinical researchers studying public health problems of importance to India. Dr. Kang was the first woman from India to be elected a Fellow of the Royal Society and also of the American Academy of Microbiology.